Allergan Breast Implant Plaintiffs Want Suits Sent to Tennessee

Suits alleging Allergan Inc. and related companies failed to disclose a link between breast implants and a rare cancer, and offered an insufficient program to cover medical costs, should be combined in a federal court in Tennessee, three women said.

The company’s Biocell silicone breast implants with a textured surface increase the risk of breast implant-associated anaplastic large cell lymphoma, a cancer of the immune system, the plaintiffs say.

Five proposed class suits have been filed to date, in five districts, the plaintiffs said in an Oct. 3 petition to the U.S. Judicial Panel on Multidistrict Litigation. Additional cases are ...